Healthcare

CoxHealth and Journeys Metabolic Partner to Tackle Metabolic Disease

Partnership accelerates CoxHealth's value-based care strategy by providing population-wide access to novel digital metabolic health programST. LOUIS, MO / ACCESSWIRE…

8 months ago

AllStar Health Brands Inc (OTC:ALST) Targets Miami for New State-of-the-Art Soccer Complex, Aiming to Elevate Youth Development to International Standards

MIAMI, FL / ACCESSWIRE / March 7, 2024 / AllStar Health Brands Inc (OTC PINK:ALST) ("AllStar" or "the Company") d/b/a…

8 months ago

Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs

ANN ARBOR, MI / ACCESSWIRE / March 7, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

8 months ago

Teladoc Health Expands Obesity & Weight Management Capabilities

Personalized health and medical care program built to improve weight related care and reduce the chronic disease complications of obesity…

8 months ago

TOMI Expands SteraMist iHP Corporate Service Contracts and Clients

Company announces new partners including The University of Texas and Rising Pharmaceuticals FREDERICK, Md., March 07, 2024 (GLOBE NEWSWIRE) --…

8 months ago

Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conference

Together with its partner, Frontage Laboratories, Telomir’s poster focused on pre-clinical data demonstrating Telomir-1’s ability to elongate telomere caps on…

8 months ago

Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,…

8 months ago

Noom Strengthens Commercial Leadership Team with Trio of Executive Healthcare Appointments

Jodi Bryant joins as President, Healthcare, Matt Moran as Chief Strategy Officer, and Cody Fair elevated to Chief Commercial Officer…

8 months ago

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Launched VOQUEZNA® (vonoprazan) tablets in November 2023 for the treatment of Erosive GERD (gastroesophageal reflux disease), achieving net revenues of…

8 months ago

Orchestra BioMed to Participate in Upcoming Investor Conferences

NEW HOPE, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”),…

8 months ago